Latest news articles
Added 3 days ago Drug news
Complete Response Letter for iclaprim to treat acute bacterial skin and skin structure infections.- Motif Bio
Motif Bio plc announced that the Company has received a Complete Response Letter (CRL) from the FDA regarding the New...
Added 10 days ago Drug news
Phase III OPTIC/OASIS-1 trials of Nuzyra in CABP and ABSSSI published in New England Journal of Medicine.- Paratek Pharma
Paratek Pharmaceuticals announced The New England Journal of Medicine (NEJM) published detailed results from the OPTIC and OASIS-1 Phase III...
Added 12 days ago Drug news
MK 7655 + Primaxin + cilastatin filed with FDA for cUTI + cIAI.- Merck Inc
Merck Inc. announced that the FDA has accepted for review regulatory filings for Priority Review for the combination of MK...
Learning Zones
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
Chronic Lymphocytic Leukaemia (CLL)
Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more
+ 1 more
Transplantation
See information on best practice in solid organ transplantation, and expert discussions on related hot topics.
Atopic Dermatitis
The Atopic Dermatitis Knowledge Centre is an educational resource, intended for healthcare professionals, that provides credible medical information on the epidemiology, pathophysiology and burden of atopic dermatitis, as well as diagnostic techniques, treatment regimens and guideline recommendations.
EADV 2018 Highlights
EADV Congress 2018: Bringing you the latest news and insights from 27th EADV Congress, 12-16 September 2018 Paris, France.
Chronic Obstructive Pulmonary Disease (COPD)
View highlights from recent congresses presented in new expert videos with leading physicians.
+ 7 more
Guidelines
Guidelines on Urological Infections
The European Association of Urology (EAU) Urological Infections Guidelines Panel has compiled these clinical guidelines to provide medical professionals with evidence-based information and recommendations for...
Added 2 years ago
The Prevention of Early-onset Neonatal Group B Streptococcal Disease
The purpose of this guideline is to provide guidance for obstetricians, midwives and neonatologists on the prevention of early-onset (less than 7 days of age) neonatal group B streptococcal (EOGBS) disease...
Added 6 years ago
Fever in under 5s: assessment and initial management
This guideline covers the assessment and early management of fever with no obvious cause in children aged under 5.
Added 5 years ago
Journal articles
Pseudomonas aeruginosa in cystic fibrosis patients with c.1652G›A (G551D)-CFTR treated with ivacaftor-Changes in microbiological parameters.
The CFTR potentiator, ivacaftor (IVA), has been widely used in the treatment of cystic fibrosis (CF) patients with the G551D mutation. To date, there has been limited information on the microbiological status...
Added 1 year ago
Early goal-directed therapy in the treatment of severe sepsis and septic shock.
Goal-directed therapy has been used for severe sepsis and septic shock in the intensive care unit.
Added 1 year ago
Early, goal-directed therapy for septic shock – a patient-level meta-analysis.
After a single-center trial and observational studies suggesting that early, goal-directed therapy (EGDT) reduced mortality from septicshock, three multicenter trials (ProCESS, ARISE, and ProMISe) showed no benefit.
Added 1 year ago
CME
Dermatological emergencies in children
- Accrediting body
-
MIMS Learning - Monthly Index of Medical Specialities
- Credits available
- 1
- Registration required
- 1
- Subscription fee
- 0
Urinary tract infection
- Accrediting body
-
MIMS Learning - Monthly Index of Medical Specialities
- Credits available
- 0
- Registration required
- 1
- Subscription fee
- 0
Testing procalcitonin in bacterial infection
- Accrediting body
-
MIMS Learning - Monthly Index of Medical Specialities
- Credits available
- 0
- Registration required
- 1
- Subscription fee
- 0